Short- and Long-Term Self-Reported Symptoms in Adolescents Aged 12–19 Years after Vaccination against SARS-CoV-2 Compared to Adolescents Not Vaccinated—A Danish Retrospective Cohort Study
This study investigated self-reported short- and long-term symptoms among adolescents receiving the BNT162b2 (Pfizer/BioNTech) vaccine against SARS-CoV-2 and those who did not. A retrospective cohort study based on Danish national survey (collected between 20 July and 15 September 2021) and register...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/10/11/1863 |
_version_ | 1797466319654748160 |
---|---|
author | Selina Kikkenborg Berg Helle Wallach-Kildemoes Line Ryberg Rasmussen Ulrikka Nygaard Henning Bundgaard Maria Nivi Schmidt Petersen Cecilie Bech Hammer Annette Kjær Ersbøll Lau Caspar Thygesen Susanne Dam Nielsen Anne Vinggaard Christensen |
author_facet | Selina Kikkenborg Berg Helle Wallach-Kildemoes Line Ryberg Rasmussen Ulrikka Nygaard Henning Bundgaard Maria Nivi Schmidt Petersen Cecilie Bech Hammer Annette Kjær Ersbøll Lau Caspar Thygesen Susanne Dam Nielsen Anne Vinggaard Christensen |
author_sort | Selina Kikkenborg Berg |
collection | DOAJ |
description | This study investigated self-reported short- and long-term symptoms among adolescents receiving the BNT162b2 (Pfizer/BioNTech) vaccine against SARS-CoV-2 and those who did not. A retrospective cohort study based on Danish national survey (collected between 20 July and 15 September 2021) and register data was conducted. Differences in short-term (<14 days) and long-term (>two months) symptoms were explored using logistic regression adjusted for confounders. A total of 747 vaccinated (first dose n = 326; second dose n = 421) and 6300 unvaccinated adolescents were included in analyses of short-term symptoms and 32 vaccinated and 704 unvaccinated adolescents in long-term symptom analyses. In the first 14 days after the first and second vaccine dose the most reported symptoms included headache and muscle or joint symptoms. In both vaccinated and unvaccinated adolescents, the 15–19-year-olds reported significantly higher proportions of all symptoms compared to the 12–14-year-olds. After the second vaccine dose vaccinated 12–14-year-olds reported significantly more headache in adjusted analyses (OR 2.20 (95% CI 1.24; 3.90)). Among the 15–19-year-olds, significantly more vaccinated adolescents reported gastrointestinal symptoms (1.38 (1.06; 1.81)), headache (1.66 (1.24; 2.22)), and tiredness (1.44 (1.08; 1.93)). No differences were found in long-term symptoms. Vaccinated adolescents reported significantly more short-term symptoms including headache, tiredness, and gastrointestinal symptoms after the second vaccine dose than unvaccinated adolescents. Long-term symptom results should be interpreted with caution due to limited sample size. |
first_indexed | 2024-03-09T18:34:11Z |
format | Article |
id | doaj.art-64468dc141d74da38face2a27091682c |
institution | Directory Open Access Journal |
issn | 2076-393X |
language | English |
last_indexed | 2024-03-09T18:34:11Z |
publishDate | 2022-11-01 |
publisher | MDPI AG |
record_format | Article |
series | Vaccines |
spelling | doaj.art-64468dc141d74da38face2a27091682c2023-11-24T07:13:53ZengMDPI AGVaccines2076-393X2022-11-011011186310.3390/vaccines10111863Short- and Long-Term Self-Reported Symptoms in Adolescents Aged 12–19 Years after Vaccination against SARS-CoV-2 Compared to Adolescents Not Vaccinated—A Danish Retrospective Cohort StudySelina Kikkenborg Berg0Helle Wallach-Kildemoes1Line Ryberg Rasmussen2Ulrikka Nygaard3Henning Bundgaard4Maria Nivi Schmidt Petersen5Cecilie Bech Hammer6Annette Kjær Ersbøll7Lau Caspar Thygesen8Susanne Dam Nielsen9Anne Vinggaard Christensen10Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Inge Lehmanns Vej 7, 2100 Copenhagen, DenmarkDepartment of Cardiology, Rigshospitalet, Copenhagen University Hospital, Inge Lehmanns Vej 7, 2100 Copenhagen, DenmarkDepartment of Cardiology, Rigshospitalet, Copenhagen University Hospital, Inge Lehmanns Vej 7, 2100 Copenhagen, DenmarkFaculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen, DenmarkDepartment of Cardiology, Rigshospitalet, Copenhagen University Hospital, Inge Lehmanns Vej 7, 2100 Copenhagen, DenmarkNational Institute of Public Health, University of Southern Denmark, Studiestræde 6, 1455 Copenhagen, DenmarkDepartment of Cardiology, Rigshospitalet, Copenhagen University Hospital, Inge Lehmanns Vej 7, 2100 Copenhagen, DenmarkNational Institute of Public Health, University of Southern Denmark, Studiestræde 6, 1455 Copenhagen, DenmarkNational Institute of Public Health, University of Southern Denmark, Studiestræde 6, 1455 Copenhagen, DenmarkFaculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen, DenmarkDepartment of Cardiology, Rigshospitalet, Copenhagen University Hospital, Inge Lehmanns Vej 7, 2100 Copenhagen, DenmarkThis study investigated self-reported short- and long-term symptoms among adolescents receiving the BNT162b2 (Pfizer/BioNTech) vaccine against SARS-CoV-2 and those who did not. A retrospective cohort study based on Danish national survey (collected between 20 July and 15 September 2021) and register data was conducted. Differences in short-term (<14 days) and long-term (>two months) symptoms were explored using logistic regression adjusted for confounders. A total of 747 vaccinated (first dose n = 326; second dose n = 421) and 6300 unvaccinated adolescents were included in analyses of short-term symptoms and 32 vaccinated and 704 unvaccinated adolescents in long-term symptom analyses. In the first 14 days after the first and second vaccine dose the most reported symptoms included headache and muscle or joint symptoms. In both vaccinated and unvaccinated adolescents, the 15–19-year-olds reported significantly higher proportions of all symptoms compared to the 12–14-year-olds. After the second vaccine dose vaccinated 12–14-year-olds reported significantly more headache in adjusted analyses (OR 2.20 (95% CI 1.24; 3.90)). Among the 15–19-year-olds, significantly more vaccinated adolescents reported gastrointestinal symptoms (1.38 (1.06; 1.81)), headache (1.66 (1.24; 2.22)), and tiredness (1.44 (1.08; 1.93)). No differences were found in long-term symptoms. Vaccinated adolescents reported significantly more short-term symptoms including headache, tiredness, and gastrointestinal symptoms after the second vaccine dose than unvaccinated adolescents. Long-term symptom results should be interpreted with caution due to limited sample size.https://www.mdpi.com/2076-393X/10/11/1863COVID-19vaccineBNT162b2adolescentsside effects |
spellingShingle | Selina Kikkenborg Berg Helle Wallach-Kildemoes Line Ryberg Rasmussen Ulrikka Nygaard Henning Bundgaard Maria Nivi Schmidt Petersen Cecilie Bech Hammer Annette Kjær Ersbøll Lau Caspar Thygesen Susanne Dam Nielsen Anne Vinggaard Christensen Short- and Long-Term Self-Reported Symptoms in Adolescents Aged 12–19 Years after Vaccination against SARS-CoV-2 Compared to Adolescents Not Vaccinated—A Danish Retrospective Cohort Study Vaccines COVID-19 vaccine BNT162b2 adolescents side effects |
title | Short- and Long-Term Self-Reported Symptoms in Adolescents Aged 12–19 Years after Vaccination against SARS-CoV-2 Compared to Adolescents Not Vaccinated—A Danish Retrospective Cohort Study |
title_full | Short- and Long-Term Self-Reported Symptoms in Adolescents Aged 12–19 Years after Vaccination against SARS-CoV-2 Compared to Adolescents Not Vaccinated—A Danish Retrospective Cohort Study |
title_fullStr | Short- and Long-Term Self-Reported Symptoms in Adolescents Aged 12–19 Years after Vaccination against SARS-CoV-2 Compared to Adolescents Not Vaccinated—A Danish Retrospective Cohort Study |
title_full_unstemmed | Short- and Long-Term Self-Reported Symptoms in Adolescents Aged 12–19 Years after Vaccination against SARS-CoV-2 Compared to Adolescents Not Vaccinated—A Danish Retrospective Cohort Study |
title_short | Short- and Long-Term Self-Reported Symptoms in Adolescents Aged 12–19 Years after Vaccination against SARS-CoV-2 Compared to Adolescents Not Vaccinated—A Danish Retrospective Cohort Study |
title_sort | short and long term self reported symptoms in adolescents aged 12 19 years after vaccination against sars cov 2 compared to adolescents not vaccinated a danish retrospective cohort study |
topic | COVID-19 vaccine BNT162b2 adolescents side effects |
url | https://www.mdpi.com/2076-393X/10/11/1863 |
work_keys_str_mv | AT selinakikkenborgberg shortandlongtermselfreportedsymptomsinadolescentsaged1219yearsaftervaccinationagainstsarscov2comparedtoadolescentsnotvaccinatedadanishretrospectivecohortstudy AT hellewallachkildemoes shortandlongtermselfreportedsymptomsinadolescentsaged1219yearsaftervaccinationagainstsarscov2comparedtoadolescentsnotvaccinatedadanishretrospectivecohortstudy AT linerybergrasmussen shortandlongtermselfreportedsymptomsinadolescentsaged1219yearsaftervaccinationagainstsarscov2comparedtoadolescentsnotvaccinatedadanishretrospectivecohortstudy AT ulrikkanygaard shortandlongtermselfreportedsymptomsinadolescentsaged1219yearsaftervaccinationagainstsarscov2comparedtoadolescentsnotvaccinatedadanishretrospectivecohortstudy AT henningbundgaard shortandlongtermselfreportedsymptomsinadolescentsaged1219yearsaftervaccinationagainstsarscov2comparedtoadolescentsnotvaccinatedadanishretrospectivecohortstudy AT marianivischmidtpetersen shortandlongtermselfreportedsymptomsinadolescentsaged1219yearsaftervaccinationagainstsarscov2comparedtoadolescentsnotvaccinatedadanishretrospectivecohortstudy AT ceciliebechhammer shortandlongtermselfreportedsymptomsinadolescentsaged1219yearsaftervaccinationagainstsarscov2comparedtoadolescentsnotvaccinatedadanishretrospectivecohortstudy AT annettekjærersbøll shortandlongtermselfreportedsymptomsinadolescentsaged1219yearsaftervaccinationagainstsarscov2comparedtoadolescentsnotvaccinatedadanishretrospectivecohortstudy AT laucasparthygesen shortandlongtermselfreportedsymptomsinadolescentsaged1219yearsaftervaccinationagainstsarscov2comparedtoadolescentsnotvaccinatedadanishretrospectivecohortstudy AT susannedamnielsen shortandlongtermselfreportedsymptomsinadolescentsaged1219yearsaftervaccinationagainstsarscov2comparedtoadolescentsnotvaccinatedadanishretrospectivecohortstudy AT annevinggaardchristensen shortandlongtermselfreportedsymptomsinadolescentsaged1219yearsaftervaccinationagainstsarscov2comparedtoadolescentsnotvaccinatedadanishretrospectivecohortstudy |